About
Ilana Fogelman, MD, MPH is a biotech executive and medical-innovation advisor focused on diagnostics and therapeutics. She is a co-founder and Senior Advisor for Medical Innovation at C2N Diagnostics and is publicly identified by Global Genes as CEO of MiCure. Earlier in her career she worked as an FDA medical reviewer and as a biotechnology equity analyst, giving her a strong regulatory, clinical-development, and diligence background.
Areas of interest
biotechmedical diagnosticsAlzheimer's diseaseneurodegenerationdrug developmentclinical trialsFDA regulatory strategymedical technology diligencerare disease advocacy